GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 104 Leadership Indicators 1. Channels / platforms where information on products and services of the entity can be accessed (provide web link, if available) . Your company’s products are displayed on their website https://india-pharma.gsk.com/en-in/products/ and specific information has been provided with respect to their names and their active ingredients. 2. Steps taken to inform and educate consumers about safe and responsible usage of products and/or services. • Your company undertakes various illness/ disease awareness sessions for public awareness of specific illnesses • Your company undertakes safe and responsible usage awareness sessions with Healthcare professionals (HCPs) via webinars and conferences. Your company’s robust digital infrastructure is a means of communicating the science behind medicines. Sales representatives are equipped with a GSK electronic tablet which has detailed information on all the products. This is used to disseminate information to Healthcare professionals (HCPs). Touch points were increased to 40 million+ across teams through enhanced use of webinars and emailers, coupled with the adoption of state-of-the-art technology platforms for virtual detailing such as Veeva Engage. • The dosage instructions for the prescriptive drugs are directed by the physicians based on the context of the patient. The product information clearly contains directives to be used only under guidance from a medical practitioner. • In case of non-prescriptive drugs, the directions for usage are mentioned. • Product information leaflets for use by Registered Medical Practitioners / Hospitals/ laboratories provide information as directed by regulatory authorities. This information includes the generic name, qualitative and quantitative composition, dosage form and strength, clinical particulars (e.g., therapeutic indication, method of administration), contraindications, special warnings and precautions for use, ability to drive and use machines and overdose. • Your Company has also conducted specific programs on antimicrobial resistance (AMR) training for pharmacists in partnership with the Common Wealth Association of pharmacists and IPA (approximately 50,000 pharmacists were trained on AMR and responsible dispensing of antibiotics) 3. Does the entity display product information on the product over and above what is mandated as per local laws? (Yes/No/Not Applicable) If yes, provide details in brief. Your company follows the regulations under the Drugs and Cosmetics Act & Rules regulations with respect to product packaging. Anticounterfeit features have also been incorporated on the packaging of some of our products. Other product information includes - • QR code for locally manufactured products to provide additional product information. • Imported products contain prescribing information leaflets for ready reference by the healthcare professional prescribing the product as per regulatory requirement. • Product packaging of some products (e.g., Nasal mist Avamys) contains additional information on the correct handing for use of the product due to past feedback received by the company on incorrect product handling for use and administration. • Toll free number is available on all product packages. Business Responsibility and Sustainability Report